RINBRI Trademark
Trademark Overview
On Friday, February 20, 2015, a trademark application was filed for RINBRI with the United States Patent and Trademark Office. The USPTO has given the RINBRI trademark a serial number of 79165950. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, September 29, 2017. This trademark is owned by Novartis AG. The RINBRI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
General Information
| Serial Number | 79165950 |
| Word Mark | RINBRI |
| Filing Date | Friday, February 20, 2015 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Friday, September 29, 2017 |
| Registration Number | 4815471 |
| Registration Date | Tuesday, September 22, 2015 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 7, 2015 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Friday, September 29, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Novartis AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Saturday, May 30, 2015 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
| Monday, June 1, 2015 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Tuesday, June 2, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 2, 2015 | ASSIGNED TO EXAMINER |
| Tuesday, June 2, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, June 6, 2015 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, June 17, 2015 | NOTICE OF PUBLICATION |
| Tuesday, July 7, 2015 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 22, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, October 22, 2015 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Friday, December 11, 2015 | FINAL DISPOSITION PROCESSED |
| Friday, December 11, 2015 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, January 8, 2016 | NOTIFICATION PROCESSED BY IB |
| Friday, October 13, 2017 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, October 13, 2017 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Friday, February 8, 2019 | NOTIFICATION PROCESSED BY IB |
| Thursday, May 28, 2026 | USPTO CORRECTION PROCESSED BY IB |
